2015
Pharmacological treatment of binge eating disorder: update review and synthesis
Reas DL, Grilo CM. Pharmacological treatment of binge eating disorder: update review and synthesis. Expert Opinion On Pharmacotherapy 2015, 16: 1463-1478. PMID: 26044518, PMCID: PMC4491373, DOI: 10.1517/14656566.2015.1053465.Peer-Reviewed Original ResearchMeSH KeywordsAnticonvulsantsAntidepressive AgentsAnti-Obesity AgentsBinge-Eating DisorderBody WeightClinical Trials, Phase III as TopicFructoseObesityRandomized Controlled Trials as TopicTopiramateWeight LossConceptsCertain medicationsWeight lossDifferent medication classesOverview of pharmacotherapyMedical comorbiditiesMedication classesMinimal weight lossFirst medicationPharmacological treatmentRecurrent bingeLong-term effectsMedicationsSuperior outcomesMental disordersPharmacotherapyEvidence baseDisorder diagnosisStatistical ManualBingePhase IIIDisordersInclusion requirementsTrialsCombination approachRCTs
2014
Current and emerging drug treatments for binge eating disorder
Reas DL, Grilo CM. Current and emerging drug treatments for binge eating disorder. Expert Opinion On Emerging Drugs 2014, 19: 99-142. PMID: 24460483, PMCID: PMC4026932, DOI: 10.1517/14728214.2014.879291.Peer-Reviewed Original ResearchMeSH KeywordsBinge-Eating DisorderClinical Trials, Phase II as TopicClinical Trials, Phase III as TopicDepressionHumansWeight LossConceptsPsychological interventionsDisorder psychopathologyWeight lossCognitive behavioral therapyCertain medicationsBinge Eating DisorderBehavioral weight lossCombination of medicationsEating DisordersBingeDrug treatmentLong-term effectsMedicationsAssociated depressionTreatment studiesPsychopathologyBED outcomesPhase IIInterventionOutcomesDepressionTrialsDisordersRemissionPharmacotherapy